Indication
1. Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy.
2. Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
3. Prevention of nausea and vomiting associated with radiotherapy.
4. Prevention of postoperative nausea and/or vomiting
Dosage Strength: Each tablet contains Ondansetron 8mg as Ondansetron Hydrochloride Dihydrate BP. oral solution: Each 5ml solution contains Ondansetron 4mg as Ondansetron Hydrochloride Dihydrate BP. Injection: Each 4 ml solution contains Ondansetron 8 mg as Ondansetron Hyd
Pack Size: Each box contains 10 tablets in blister pack, Each bottle contains 50 ml solution in pet bottle., Each box contains 6 ampoules in blister pack